Skip to main content
Top
Published in: Comparative Hepatology 1/2004

Open Access 01-01-2004 | Proceedings

The regulatory role of prostaglandin E2in liver (patho) physiology is controlled at its site of synthesis and its action on the receptors

Authors: Peter Dieter, Roland Scheibe, Yefgeniya Bezugla, Egbert Matthé, Sandra Schuch, Lars Treffkorn, Brigitte Bernard, Sabine Kamionka, Angelika Kolada

Published in: Comparative Hepatology | Special Issue 1/2004

Login to get access

Excerpt

Among the hormone class of the eicosanoids, PGE2 plays a predominant role in liver (patho) physiology. Liver-specific responses, like regulation of blood glucose homeostasis, sinusoidal blood flow within the liver, properties of the transendothelial barrier within the liver, synthesis and release of important other mediators like cytokines, growth factors or nitric oxide, and liver fibrogenesis have been shown to be mediated or regulated by PGE2 [1]. Within the liver, the main producers of PGE2 are the Kupffer cells. The synthesis of PGE2 in Kupffer cells is controlled at multiple levels. The action of PGE2 on its target cells is mediated by 4 classes of PGE2 receptors (EP1, EP2, EP3, EP4). Each of these receptors converts the information of PGE2 by different intracellular signal pathways to a specific cellular response [2]. …
Literature
1.
go back to reference Dieter P, Scheibe R, Télzer S, Kamionka S, Kolada A: Prostaglandin E2, an important regulator in (patho) physiological liver functions. In: Cells of the Hepatic Sinusoid. Edited by: Wisse E, Knook DL, de Zanger R, Arthur MJP. 1999, Leiden, Kupffer Cell Foundation, 8: 6-10. Dieter P, Scheibe R, Télzer S, Kamionka S, Kolada A: Prostaglandin E2, an important regulator in (patho) physiological liver functions. In: Cells of the Hepatic Sinusoid. Edited by: Wisse E, Knook DL, de Zanger R, Arthur MJP. 1999, Leiden, Kupffer Cell Foundation, 8: 6-10.
2.
go back to reference Fennekohl A, Segi E, Sugimoto Y, Ichikawa A, Péschel GP: Parallel action of EP2 and EP4 receptor for the prostaglandin E2-mediated feedback inhibition of the LPS-induced TNF-alpha formation in mouse Kupffer cells. In: Cells of the Hepatic Sinusoid. Edited by: Wisse E, Knook DL, de Zanger R, Arthur MJP. 2001, Leiden, Kupffer Cell Foundation, 8: 11-14. Fennekohl A, Segi E, Sugimoto Y, Ichikawa A, Péschel GP: Parallel action of EP2 and EP4 receptor for the prostaglandin E2-mediated feedback inhibition of the LPS-induced TNF-alpha formation in mouse Kupffer cells. In: Cells of the Hepatic Sinusoid. Edited by: Wisse E, Knook DL, de Zanger R, Arthur MJP. 2001, Leiden, Kupffer Cell Foundation, 8: 11-14.
Metadata
Title
The regulatory role of prostaglandin E2in liver (patho) physiology is controlled at its site of synthesis and its action on the receptors
Authors
Peter Dieter
Roland Scheibe
Yefgeniya Bezugla
Egbert Matthé
Sandra Schuch
Lars Treffkorn
Brigitte Bernard
Sabine Kamionka
Angelika Kolada
Publication date
01-01-2004
Publisher
BioMed Central
Published in
Comparative Hepatology / Issue Special Issue 1/2004
Electronic ISSN: 1476-5926
DOI
https://doi.org/10.1186/1476-5926-2-S1-S35

Other articles of this Special Issue 1/2004

Comparative Hepatology 1/2004 Go to the issue

Preface

Preface

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine